Teleflex Incorporated logo

Teleflex Incorporated (TFX)

Market Closed
15 Oct, 08:00 PM
NYSE NYSE
$
128. 22
+4.93
+3.9987%
$
5.43B Market Cap
- P/E Ratio
0.54% Div Yield
907,000 Volume
- Eps
$ 123.29
Previous Close
Add Transaction
Day Range
123.75 128.59
Year Range
100.18 145
Want to track TFX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TFX or SONVY: Which Is the Better Value Stock Right Now?

TFX or SONVY: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and SONOVA HOLDING (SONVY). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 1 week ago
Is It Prudent to Add Teleflex Stock to Your Portfolio Now?

Is It Prudent to Add Teleflex Stock to Your Portfolio Now?

TFX's Vascular growth, Asia expansion and improved leverage support the outlook, but tariffs, input costs and margin pressure remain key risks.

Zacks | 1 week ago
Here's Why Teleflex (TFX) is a Strong Value Stock

Here's Why Teleflex (TFX) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 4 weeks ago
TFX vs. PEN: Which Stock Is the Better Value Option?

TFX vs. PEN: Which Stock Is the Better Value Option?

Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks is more attractive to value investors?

Zacks | 1 month ago
Should You Add Teleflex Stock to Your Portfolio Now?

Should You Add Teleflex Stock to Your Portfolio Now?

TFX's Vascular growth, Interventional expansion and improved leverage support its outlook, while currency volatility remains a key risk.

Zacks | 1 month ago
TFX or PEN: Which Is the Better Value Stock Right Now?

TFX or PEN: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks | 1 month ago
Is TFX a Buy Now as Valuation Improves but Execution Risks Remain?

Is TFX a Buy Now as Valuation Improves but Execution Risks Remain?

Valuation is improving for Teleflex, but slower Vascular Intervention integration and margin pressure keep execution risks in focus.

Zacks | 1 month ago
Can Teleflex's OEM Sale and Higher EPS Outlook Reshape 2026 Returns?

Can Teleflex's OEM Sale and Higher EPS Outlook Reshape 2026 Returns?

TFX's $1.5B OEM sale cuts leverage and lifts 2026 EPS guidance, but weaker growth and margin pressure keep the outlook measured.

Zacks | 1 month ago
TFX vs. PEN: Which Stock Is the Better Value Option?

TFX vs. PEN: Which Stock Is the Better Value Option?

Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks presents investors with the better value opportunity right now?

Zacks | 2 months ago
Why Teleflex (TFX) International Revenue Trends Deserve Your Attention

Why Teleflex (TFX) International Revenue Trends Deserve Your Attention

Evaluate Teleflex's (TFX) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Zacks | 2 months ago
Teleflex Q2 Earnings Call Highlights

Teleflex Q2 Earnings Call Highlights

Teleflex NYSE: TFX reported second-quarter revenue and adjusted earnings above its expectations, supported by strong growth in its Vascular and Surgical businesses, while slower-than-anticipated integration of its acquired Vascular Intervention business weighed on Interventional results.

Marketbeat | 2 months ago
Teleflex Incorporated (TFX) Q2 2026 Earnings Call Transcript

Teleflex Incorporated (TFX) Q2 2026 Earnings Call Transcript

Teleflex Incorporated (TFX) Q2 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
Loading...
Load More